Integrative Genetic, Molecular Simulation, and Surface Plasmon Resonance Analysis of Shierwei Wenxiao Decoction-Related Candidate Interactions in Cystic Kidney Disease.
文献摘要
Introduction To integrate genetic, computational, and biophysical evidence to prioritize candidate gene-expression signals and compound-protein interactions that are potentially relevant to cystic kidney disease and the Shierwei Wenxiao Decoction. Methods Kidney-cortex expression Quantitative Trait Locus (eQTL) data and FinnGen R11 summary statistics were integrated through summary-data-based Mendelian Randomization (SMR), HEIDI testing, formal colocalization, and independent renal eQTL replication. A database-derived compound library was screened against protein-coding candidate targets using molecular docking. Two prioritized compound-protein pairs underwent molecular dynamics simulations, MM/GBSA binding-energy estimation, and Surface Plasmon Resonance (SPR) assessment. Results SMR identified 13 nominal associations between gene expression and a composite cystic kidney disease phenotype (P_SMR 0.05), but none survived false discovery rate correction. Formal colocalization identified no robust shared causal signals under default priors, including those in the HLA region. HLA-DRB6 was reannotated as a pseudogene and excluded from protein-focused analyses, leaving nine protein-coding candidate targets. FAM118A and LDHC showed reproducible renal eQTL signals, although colocalization remained inconclusive. Docking, molecular dynamics, and SPR findings supported candidate physical interactions under the respective experimental and computational conditions. Discussion The findings provide a framework for candidate prioritization, while uncertainties in genetic causality, compound exposure, and target engagement limit mechanistic interpretation. Observed binding does not demonstrate target modulation, disease efficacy, or formula-specific pharmacological activity without direct functional validation in relevant disease models. Conclusion These exploratory findings nominate genetic signals and compound-protein interactions for follow-up investigation. Independent genetic, phytochemical, functional, and disease-model studies are needed before therapeutic relevance can be established.